Tag
Montana's new right-to-try law allows biotech companies to sell experimental drugs after minimal testing, a move that is both hopeful for patients and concerning to ethicists.
Montana's new right-to-try law offers hope to families like Kris DeVault's, whose son Brody has a rare genetic condition that an experimental, unapproved drug might help treat.
Montana's expanded right-to-try law now allows any biotech company to sell experimental drugs to consumers after a review, with the first clinics expected later this year. The law, driven by longevity advocates, raises concerns about oversight and safety.